Previous Section Index Home Page

13 Feb 2006 : Column 1749W—continued

Young Offenders

Andrew Rosindell: To ask the Secretary of State for the Home Department how many arrests of minors were made in Wales in each of the last five years. [48561]

Fiona Mactaggart: Information available on arrests of minors in Wales is given in the table.
Number of persons aged 10–17 arrested for recorded crime (notifiable offences), Wales

Total notifiable offences
2000–01(49)15,817
2001–02(49)16,021
2002–0319,446
2003–0419,930
2004–0519,135


(49) Gwent was unable to supply arrests data by age group and therefore excluded from the total.

HEALTH

Fuel for Living" Booklet

Mr. Lansley: To ask the Secretary of State for Health what the cost has been of the development of the Fuel for Living" booklet; how many copies of the booklet will be published; at what cost; and if she will make a statement. [42189]

Caroline Flint: The cost of developing the Fuel for Living" recipe booklet was £27,000. One million copies of the booklet have been produced at a cost of £58,500.

The Fuel for Living" recipe booklet is part of the 5 A DAY campaign, which provides information and practical advice to improve the diet. The booklet targets the young independent group of 16 to 24-year-olds, who have a lower than average intake of fruit and vegetables so there is a need to provide information and help to improve their diet.
 
13 Feb 2006 : Column 1750W
 

Health Reform in England; Update and Next Steps"

Mr. Meacher: To ask the Secretary of State for Health in respect of the proposed NHS reforms outlined in Health Reform in England; update and next steps", whether practice based contracting will apply to all care or only to non-hospital care. [47469]

Mr. Byrne: The only services that are outside the scope of practice based commissioning for 2006–07 are services that are commissioned regionally or nationally and core general practitioner services.

ADHD

Tim Loughton: To ask the Secretary of State for Health (1) if she will list the attention deficit hyperactivity disorder support groups which receive funding from the NHS; and how much each has received in 2005–06; [48075]

(2) what recent discussions have taken place between her Department and attention deficit hyperactivity disorder support groups. [48076]

Mr. Byrne: Information about national health service support for attention deficit hyperactivity disorder support groups is not collected centrally. However, the Department currently supports one attention deficit hyperactivity disorder support group via the section 64 grant scheme. In 2005–06, the National Attention Deficit Disorder Information and Support Service are receiving £40,000 as a contribution towards their central administrative costs.

Adverse Drug Reactions

Mr. Lansley: To ask the Secretary of State for Health how many patient reports of adverse drug reactions have been received (a) online and (b) through a yellow card form in each month since patients were permitted to report adverse drug reactions directly. [46402]

Jane Kennedy: Reports of suspected adverse drug reaction (ADR) reports are collected by the Medicines and Healthcare products Regulatory Agency (MHRA) and Commission for Human Medicines (CHM) through the spontaneous reporting scheme, the yellow card scheme.

Following recommendations from an independent review of access to the yellow card scheme, patients and their representatives are now encouraged to report suspected adverse drug reactions directly to the MHRA and CHM. Direct reporting from patients was launched as a small-scale pilot in January 2005 and expanded to a United Kingdom-wide pilot in October 2005. Patients are able to submit reports both electronically and via a purpose designed paper yellow card.

The table shows the total number of patient adverse drug reaction (ADR) reports received each month between 17 January 2005 and 31 December 2005, along with a breakdown of the number of paper and electronic internet reports.
 
13 Feb 2006 : Column 1751W
 

Number of ADR reports received from patients between 17 January and 31 December 2005

Received
month (2005)
TotalPaper
yellow card
Internet
yellow card
January31328
February583028
March704228
April824834
May633132
June673334
July602832
August12927102
September732746
October(50)692247
November793841
December16913435


(50) UK-wide direct patient reporting was launched on 25 October 2005

It is important to note that the submission of a suspected ADR report does not necessarily mean that it was caused by the drug. Many factors have to be taken into account in assessing causal relationships, including temporal association, the possible contribution of concomitant medication and the underlying disease.

Alcohol Consumption

Mr. Jenkins: To ask the Secretary of State for Health what assessment her Department has made of the effects of drinking alcohol (a) socially and (b) alone; and what assessment she has made of the different effects of drinking particular alcoholic drinks. [46213]

Caroline Flint: The Department has not made an assessment of the effects of drinking alcohol socially versus alone or of the different effects of drinking particular alcoholic drinks.

Sensible Drinking: Report of an inter-departmental working group (1995)" sets out the Department's guidance on alcohol consumption and suggests:

The Department keeps the evidence of the harmful effects of alcohol under ongoing review to ensure messages are accurate and up to date.

Alcohol Dependence

Kelvin Hopkins: To ask the Secretary of State for Health what her Department estimates to be the prevalence service utilisation ratio for alcohol-dependent individuals accessing treatment in (a) England and (b) each region. [45217]

Caroline Flint [holding answer 24 January 2006]: The Government's alcohol needs assessment research project (ANARP) research, published in November 2005, estimates the gap between those alcohol-dependent individuals seeking treatment and the level of treatment services that is available.

The prevalence service utilisation ratio for alcohol-dependent individuals accessing treatment in England and each region is shown in the table.
 
13 Feb 2006 : Column 1752W
 

England


Gender
Prevalence service utilisation in need of treatment/in treatment
Male20.8
Female12.4
All (Average) Regions18.0
East Midlands15.7
Eastern31.2
London13.2
North East101.9
North West11.8
South East20.2
South West14.3
West Midlands15.3
Yorkshire and Humber46.0

Alimta

Jon Cruddas: To ask the Secretary of State for Health if she will make a statement on the availability of Alimta on the NHS. [46360]

Jane Kennedy: Alimta is licensed for the treatment of malignant pleural mesothelioma and can be prescribed across the national health Service for those patients who fit the licensed criteria with the agreement of the clinicians and primary care trusts (PCTs) concerned.

The National Institute for Health and Clinical Excellence (NICE) is appraising Alimta for the treatment of mesothelioma and guidance is expected in October 2006.

Funding for licensed treatments should not be withheld because guidance from NICE is unavailable. In these circumstances, we expect PCTs to take full account of available evidence when reaching funding decisions. This is confirmed in Health Service Circular 1999/176", which asks NHS bodies to continue with local arrangements for the managed introduction of new technologies where guidance from NICE is not available at the time the treatment or technology first became available.


Next Section Index Home Page